The Josep Carreras Leukaemia Research Institute (IJC) is a comprehensive cancer research center dedicated to conduct research and drive innovation in the epidemiological, preventive, clinical, translational, and basic aspects of leukaemia and other hematologic malignancies, with the final aim of finding a cure for these diseases. It was created in 2010, and since then has experienced an exponential growth.
The IJC is also part of the network of Excellence Research Centers of Catalonia (CERCA) and was accredited as a Severo Ochoa Center of Excellence by the Ministry of Science, Innovation, and Universities in 2024. Since 2018, the Institute has also been accredited by the Scientific Foundation of the Spanish Association Against Cancer (FCAECC) Additionally, IJC is one of the centers integrated into the Institut de Recerca Germans Trias i Pujol (IGTP) accreditation as Accredited Health Research Institute (IIS) by the Carlos III Health Institute (ISCIII).
The IJC's main headquarters is located within the Can Ruti Biomedical Campus, alongside other leading biomedical institutions, providing direct access to cutting-edge scientific and technological facilities, as well as complementary community services. The IJC has six locations integrated into reference hospitals: Hospital Germans Trias i Pujol, Hospital Clínic, Hospital Sant Pau, Hospital Josep Trueta, Hospital del Mar and Hospital San Joan de Déu. This facilitates close collaboration between basic and clinical researchers, fostering translational research that integrates basic science with clinical practice in clinical settings.
The Josep Carreras Leukaemia Research Institute (IJC), is seeking for a motivated GENOMICS PLATFORM TECHNICIAN IN TRAINING. The Genomics unit is a scientific and technological support unit for high level research projects in the Genomics and Epigenomics fields and assist researchers from the experimental design to the data analysis and interpretation. The Unit is equipped with state-of-the-art instruments for microarray-based genome-wide DNA methylation assessment and microarray-based genotyping, NGS targeted sequencing solutions and pyrosequencing to analyse loci specific DNA methylation status.
MAIN RESPONSABILITIES
Support for internal and external projects developed in the Unit.
DNA isolation from a range of sample types (primary cells, cell lines, frozen and paraffin-embedded tissues).
Nucleic acid quantification and quality control assessment using fluorometry and electrophoresis analysis.
Sample processing for array-based applications such as DNA Methylation analysis and SNP Genotyping (Illumina Infinium Assay).
Use of Illumina MiSeq-DX and MiSeqi100Plus instruments for Next Generation Sequencing protocols.
Keeping audit trails of the work performed, writing, and keeping up-to-date documentation such as Standard Operation Procedures (SOPs).
Sample reception and logging.
Laboratory stock and orders management.
Reporting to the Unit Manager.
WHAT WE NEED
Educational background in biology or a related field (hold a higher training cycle or higher degree).
Experience in molecular biology procedures such as PCR, RT-qPCR, and DNA/RNA purification procedures.
Excellent organizational, management, communication, and interpersonal skills.
Ability to teamwork in a dynamic environment and to handle varying workloads.
Responsible, proactive, self-motivated, and able to work with a high degree of autonomy.
Client and collaborators-oriented attitude and strong problem-solving skills.
Good level of writing and speaking English.
Experience in MS Office Suite.
Desirable but not required
Experience in preparation of sequencing libraries for next generation sequencing.
Experience in validation of NGS or array results by pyrosequencing.
Experience in the use of databases and genomic tools.
WHAT WE OFFER
6-month fixed-term contract, extendable up to 1 year (Contrato formativo para la obtención de la práctica profesional).
Full time contract.
Incorporation in a multinational and highly collaborative team.
International network of the Institute.
Working in the mixed basic and clinical research environment of the Josep Carreras Leukaemia Research Institute.
The stimulating environment of the Barcelona metropolitan area.
Competitive Salary to be further defined depending on candidate experience.
The stimulating environment of the IJC and its scientific network.
DEADLINE
To apply for this opportunity, please submit your application by August 31, 2026.
WHO WE ARE?
The mission of the Josep Carreras Leukaemia Research Institute is to conduct research and drive innovation in the epidemiological, preventive, clinical, translational, and basic aspects of cancer, with a special emphasis on Leukaemia and other malignant blood diseases, with the aim of finding a cure for these diseases.
The IJC’s vision is to be a world-class reference and excellent research center that contributes to the improvement of results, and the cure of patients affected by leukaemia and other malignant haemopathies, through innovation, sustainability, social responsibility, talent, and professional experience.
In 2019, IJC was honored with the “Human Resources Excellence in Research Award” by the European Commission, recognizing the alignment of our human resources policies with the European Charter for Researchers and Code of Conduct for the Recruitment of Researchers. The Human Resources Strategy for Researchers (HRS4R) guides research centers of excellence in implementing and upholding these standards within their policies, emphasizing training, professional development, and mobility opportunities.
The IJC’s commitment to these values and principles strengthens our internal policies and ensures that our members have the optimal conditions and environment for their professional development.
The Board of Trustees is composed of representatives of the Generalitat de Catalunya (regional government), University of Barcelona, Autonomous University of Barcelona, the City of Badalona and the Jose Carreras International Leukaemia Foundation
The Catalan government provides hard money on an annual basis. The Jose Carreras International Leukaemia Foundation provides start-up funds, project funds as well as financial support for investments.
The JCI has an international scientific advisory board served by prominent researchers from US and Europe.
The IJC has been awarded ERC and other EU grants.
The IJC is an equal-opportunity employer. We evaluate qualified applicants without regard to race, color, religion, sex, national origin, disability, or other legally protected characteristics.
